RTOG Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.rtog.org

Clinical Trials

Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2004-05-26

Last Posted Date: 2020-10-22

Lead Sponsor: Radiation Therapy Oncology Group

Registration Number: NCT00005088

Locations: 🇺🇸
Mount Diablo Medical Center, Concord, California, United States
🇺🇸
Urology Associates - Mobile AL, Mobile, Alabama, United States
🇺🇸
Walter Reed Army Medical Center, Washington, District of Columbia, United States

and more 255 locations

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Radiation: 3D-CRT

First Posted Date: 2004-05-26

Last Posted Date: 2020-01-10

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 1084

Registration Number: NCT00002602

Locations: 🇺🇸
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States
🇺🇸
Mobile Infirmary Medical Center, Mobile, Alabama, United States

and more 225 locations

Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy

Phase 3

Completed

Conditions: Radiation Enteritis
Diarrhea

First Posted Date: 2004-05-03

Last Posted Date: 2020-10-19

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 174

Registration Number: NCT00003825

Locations: 🇺🇸
Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
CCOP - Atlanta Regional, Atlanta, Georgia, United States
🇺🇸
CCOP - Columbus, Columbus, Ohio, United States

and more 257 locations

Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases

Phase 3

Completed

Conditions: Metastatic Cancer

Interventions: Procedure: surgical procedure
Radiation: radiation therapy
Radiation: stereotactic radiosurgery

First Posted Date: 2004-04-13

Last Posted Date: 2013-11-19

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 333

Registration Number: NCT00002708

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
🇺🇸
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States

and more 255 locations

Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

First Posted Date: 2004-04-08

Last Posted Date: 2015-11-17

Lead Sponsor: Radiation Therapy Oncology Group

Registration Number: NCT00081302

Locations: 🇺🇸
Arlington Cancer Center - Arlington, Arlington, Texas, United States

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer

Interventions: Radiation: Radiation Therapy
Drug: Capecitabine 1200 mg/m^2/day
Drug: Capecitabine 1650 mg/m^2/day
Drug: Oxaliplatin
Drug: Irinotecan
Procedure: Surgery
Drug: Folinic Acid
Drug: Fluorouracil

First Posted Date: 2004-04-08

Last Posted Date: 2020-02-27

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 146

Registration Number: NCT00081289

Locations: 🇺🇸
Baptist-South Miami Regional Cancer Program, Miami, Florida, United States
🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States
🇺🇸
Ingalls Cancer Care Center at Ingalls Memorial Hospital, Harvey, Illinois, United States

and more 2 locations

Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases

Not Applicable

Completed

Conditions: Radiation Toxicity
Cognitive/Functional Effects
Metastatic Cancer

Interventions: Procedure: management of therapy complications
Procedure: quality-of-life assessment

First Posted Date: 2004-03-08

Last Posted Date: 2020-10-22

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 59

Registration Number: NCT00007007

Locations: 🇺🇸
Mount Diablo Medical Center, Concord, California, United States
🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸
Harbor Hospital Center, Baltimore, Maryland, United States

and more 238 locations

Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Phase 1

Completed

Conditions: Lung Cancer

First Posted Date: 2004-02-27

Last Posted Date: 2013-11-19

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 36

Registration Number: NCT00002577

Locations: 🇺🇸
Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
🇺🇸
Mercy Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States

and more 239 locations

Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Phase 3

Completed

Conditions: Prostate Cancer

Interventions: Radiation: radiation therapy
Drug: flutamide
Drug: Zoladex
Drug: Lupron

First Posted Date: 2004-02-27

Last Posted Date: 2018-06-14

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 2028

Registration Number: NCT00002597

Locations: 🇺🇸
New York Medical College, Valhalla, New York, United States
🇺🇸
Wilkes Barre General Hospital, Wilkes-Barre, Pennsylvania, United States
🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States

and more 236 locations

External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Radiation: brachytherapy
Radiation: iodine I 125
Radiation: radiation therapy

First Posted Date: 2004-02-26

Last Posted Date: 2020-10-22

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 138

Registration Number: NCT00006365

Locations: 🇺🇸
CCOP - Columbus, Columbus, Ohio, United States
🇺🇸
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States
🇺🇸
Hahnemann University Hospital, Philadelphia, Pennsylvania, United States

and more 251 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy